Comparative study of dexamethasone versus dexmedetomidine as adjuvants to 0.25% bupivacaine in transversus abdominis plane block for post-operative analgesia in lower segment cesarean section
DOI:
https://doi.org/10.71152/ajms.v16i6.4523Keywords:
Post-operative analgesia; Transversus abdominis plane block; Dexamethasone; dexmedetomidine; Cesarean section; Bupivacaine; Regional anesthesiaAbstract
Background: Effective post-operative pain management is essential for patient comfort and recovery after a lower segment cesarean section (LSCS).
Aims and Objectives: This study compares dexamethasone and dexmedetomidine as adjuvants to 0.25% bupivacaine in TAP block for post-operative analgesia after LSCS. The objectives are to assess analgesia duration in both groups, compare pain intensity using Visual Analog Scale (VAS) scores at multiple intervals, evaluate rescue analgesia consumption within 48 h, and analyze patient satisfaction with analgesia.
Materials and Methods: A randomized, single-blinded study included 60 parturients (American Society of Anesthesiologists) undergoing LSCS under spinal anesthesia. They were randomized into: Group DEXA: 0.25% bupivacaine (40 mL)+8 mg dexamethasone, Group DEXMED: 0.25% bupivacaine (40 mL)+1 mcg/kg dexmedetomidine. Pain was assessed using VAS at 0, 2, 4, 6, 12, 18, 24, 36, and 48 h. Total analgesia duration, rescue analgesic use, and patient satisfaction were recorded. Statistical analysis used SPSS 2021 (P<0.05 significant).
Results: Analgesic duration was significantly longer in DEXMED (24.39±4.14 h) vs. DEXA (15.43±2.81 h, P=0.0001). VAS scores were significantly lower in DEXMED at 6, 12, 18, 24, and 36 h (P<0.0001). Rescue analgesia use was lower in DEXMED (P=0.0001). Patient satisfaction was slightly higher in DEXMED (P=0.337).
Conclusion: Dexmedetomidine provides prolonged analgesia, lower pain scores, and reduced analgesic consumption, making it a superior adjuvant to bupivacaine in TAP block for LSCS pain management.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Asian Journal of Medical Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who publish with this journal agree to the following terms:
- The journal holds copyright and publishes the work under a Creative Commons CC-BY-NC license that permits use, distribution and reprduction in any medium, provided the original work is properly cited and is not used for commercial purposes. The journal should be recognised as the original publisher of this work.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
